Spliceosomal mutation drives melanoma tumorigenesis via lineage-specific RAS activation
Science Advances · 2026
DOI: 10.1126/sciadv.adz8289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Ruixin Jiang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: RNA Splicing Factors, Melanoma, ras Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: GenScript, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Shanghai.
Abstract (Originalsprache)
Mutations in splicing factors are recurrent across human cancers and drive widespread RNA splicing dysregulation. Among these, SF3B1 is the most frequently mutated, yet its hotspot mutations exhibit lineage specificity, with SF3B1 R625 mutations predominantly found in melanoma and SF3B1 K700E in hematologic malignancies. However, the mechanistic basis for this cancer-type specificity remains unclear. Here, we demonstrate that SF3B1 R625H induces greater activation of alternative 3′ splice site than SF3B1 K700E . Mechanistically, the polyadenine-enriched sequence surrounding cryptic branch point sites confers SF3B1 R625H selective advantage in aberrant splicing. This splicing bias leads to preferential missplicing of NF1 , a RAS inhibitor, resulting in RAS hyperactivation and accelerated melanoma progression in mouse models. This study redefines the oncogenic paradigm of SF3B1 mutations by demonstrating that distinct hotspot mutations exploit lineage-specific splicing vulnerabilities to drive tumorigenesis and establishes RAS activation as key mechanism underlying SF3B1 R625H -driven melanoma, positioning RAS pathway as tractable therapeutic target in SF3B1 -mutant melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Computational Biology, China National Center for Bioinformation, Beijing, China.
- Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Ruixin Jiang, Peiqi Xing, Jindou Xie, Yuzhu Zhang, Yanjie Zhang, A Hunter Shain, Ming Lei, Robert L Judson-Torres, Zhaoqi Liu, Hanlin Zeng
Förderung
- GenScript
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality, Shanghai
- National key R&D program of China
- The Chinese Academy of Sciences Hundred Talents Program
- CNCB initiative program
- the Class IV Peak Disciplines
- the Innovative Research Team of High-Level Local Universities from the Shanghai Municipal Education Commission
Zitieren
APA
Jiang, R., Xing, P., Xie, J., Bai, G., Zhang, Y., Hou, P., Luo, H., Ma, Y., Liu, R., Zheng, Y., Chen, X., Jiang, B., Huang, J., Zhang, Y., Shain, A. H., Lei, M., Judson-Torres, R. L., Ye, J., Liu, Z., & Zeng, H. (2026). Spliceosomal mutation drives melanoma tumorigenesis via lineage-specific RAS activation. Science Advances. https://doi.org/10.1126/sciadv.adz8289
Vancouver
Jiang R, Xing P, Xie J, Bai G, Zhang Y, Hou P, et al. Spliceosomal mutation drives melanoma tumorigenesis via lineage-specific RAS activation. Science Advances. 2026. doi:10.1126/sciadv.adz8289
BibTeX
@article{Jiang2026,
author = {Jiang, Ruixin and Xing, Peiqi and Xie, Jindou and Bai, Gang and Zhang, Yuzhu and Hou, Pengcong and Luo, Hao and Ma, Yanni and Liu, Ruixin and Zheng, Yang and Chen, Xiangyu and Jiang, Bin and Huang, Jing and Zhang, Yanjie and Shain, A Hunter and Lei, Ming and Judson-Torres, Robert L and Ye, Jing and Liu, Zhaoqi and Zeng, Hanlin},
title = {Spliceosomal mutation drives melanoma tumorigenesis via lineage-specific RAS activation},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adz8289}
}
EUVIMED